Phosphonoacetate Modifications Enhance the Stability and Editing Yields of Guide RNAs for Cas9 Editors

• Published in: Biochemistry (Easton) Vol. 62; no. 24; pp. 3512 - 3520
• Main Authors: Ryan, Daniel E., Diamant-Levi, Tamar, Steinfeld, Israel, Taussig, David, Visal-Shah, Savita, Thakker, Suhani, Lunstad, Benjamin D., Kaiser, Robert J., McCaffrey, Ryan, Ortiz, Michael, Townsend, Justin, Welch, William R. W., Singh, Mandeep, Curry, Bo, Dellinger, Douglas J., Bruhn, Laurakay
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 19.12.2023
• Subjects: CRISPR-Cas Systems; Gene Editing - methods; Humans; Phosphonoacetic Acid; RNA, Guide, CRISPR-Cas Systems; RNA, Messenger
• ISSN: 0006-2960; 1520-4995
• DOI: 10.1021/acs.biochem.1c00768

CRISPR gene editing and control systems continue to emerge and inspire novel research and clinical applications. Advances in CRISPR performance such as optimizing the duration of activity in cells, tissues, and organisms, as well as limiting off-target activities, have been extremely important for expanding the utility of CRISPR-based systems. By investigating the effects of various chemical modifications in guide RNAs (gRNAs) at defined positions and combinations, we find that 2′-O-methyl-3′-phosphonoacetate (MP) modifications can be substantially more effective than 2′-O-methyl-3′-phosphorothioate (MS) modifications at the 3′ ends of single-guide RNAs (sgRNAs) to promote high editing yields, in some instances showing an order of magnitude higher editing yield in human cells. MP-modified 3′ ends are especially effective at promoting the activity of guide RNAs cotransfected with Cas messenger RNA (mRNA), as the gRNA must persist in cells until the Cas protein is expressed. We demonstrate such an MP enhancement for sgRNAs cotransfected with a BE4 mRNA for cytidine base editing and also demonstrate that MP at the 3′ ends of prime editing guide RNAs (pegRNAs) cotransfected with PE2 mRNA can promote maximal prime editing yields. In the presence of serum, sgRNAs with MP-modified 3′ ends showed marked improvements in editing efficiency over sgRNAs with MS-modified 3′ ends codelivered with Cas9 mRNA and showed more modest improvements at enhancing the activity of transfected ribonucleoprotein (RNP) complexes. Our results suggest that MP should be considered as a performance-enhancing modification for the 3′ ends of synthetic gRNAs, especially in situations where the guide RNAs may be susceptible to exonuclease-mediated degradation.